Adrenocortical carcinoma is a rare malignancy with an annual worldwide incidence of 1–2
cases per 1 million and a 5-year survival rate of< 60%. Although adrenocortical carcinoma is …

Adrenocortical carcinoma (ACC) is a rare cancer with a poor prognosis. Unlike many other
cancers, there has been little improvement in patient outcome over the past several …

Adrenocortical carcinoma (ACC) is a rare, aggressive cancer with still partially unknown
pathogenesis, heterogenous clinical behaviour and no effective treatment for advanced …

Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy that generally conveys a
poor prognosis. Currently, surgical resection is considered the lone curative treatment …

Adrenocortical carcinoma (ACC) is a very rare and aggressive tumor with dismal outcomes.
Best current treatments include complete surgical resection for localized resectable disease …

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy defined by a
heterogeneous clinical presentation, dismal prognosis, and lack of effective therapeutic …

Adrenocortical carcinomas are rare tumors with poor prognosis and limited treatment
options. Although widely used as in vitro models to test novel therapeutic strategies, the …

Adrenocortical carcinoma (ACC) is an aggressive and rare neoplasm that originates in the
cortex of the adrenal gland. The disease is associated with heterogeneous but mostly poor …

Adrenocortical carcinoma is a rare endocrine tumor with a poor prognosis. These tumors
can be diagnostically challenging, and diagnostic algorithms and criteria continue to be …

Adrenocortical carcinoma is a relatively rare and heterogenous malignancy with evolving
diagnostic and therapeutic approaches. The majority of previous information, mainly derived …